A Study of LY2963016 Compared to Lantus® in Adult Chinese Participants With Type 1 Diabetes Mellitus
Status:
Completed
Trial end date:
2020-03-05
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare long-acting basal insulin analog LY2963016 to Lantus®
in combination with mealtime insulin lispro in adult Chinese participants with Type 1
Diabetes Mellitus (T1DM).